Milestone Scientific Offers Insightful Online Investor Presentation
Milestone Scientific Director Sells $2,800 in Stock
12 Health Care Stocks Moving In Monday's Pre-Market Session
Milestone Scientific: A Strong Buy on Robust Financials and Market Expansion Potential
Maxim Group Maintains Milestone Scientific(MLSS.US) With Buy Rating, Maintains Target Price $3
Milestone Scientific Inc. (MLSS) Q2 2024 Earnings Call Transcript Summary
Milestone Scientific GAAP EPS of $0.00 Beats by $0.01, Revenue of $1.9M Misses by $0.62M
Express News | Milestone Scientific Q2 Sales $1.85M Miss $2.52M Estimate
Express News | Milestone Scientific Provides Business Update and Reports Financial Results for the Second Quarter of 2024
Express News | Milestone Scientific Q2 EPS USD 0
Express News | Milestone Scientific Q2 Net Income USD 200 Thousand
Express News | Milestone Scientific Q2 Revenue USD 1.3 Million
Milestone Scientific | 10-Q: Q2 2024 Earnings Report
Milestone Scientific Schedules Second Quarter 2024 Financial Results and Business Update Conference Call
Milestone Scientific Announces Strategic Partnership With Axial Biologics to Distribute CompuFlo in New Jersey, Texas, and Florida
Express News | Milestone Scientific Announces Strategic Partnership With Axial Biologics to Distribute Compuflo® in New Jersey, Texas, and Florida
Express News | Milestone Scientific Receives Multiple Notices Of Allowance For Key Patent Applications In U.S. And Europe; Advances Painless And Precise Drug Delivery Instruments
Express News | Milestone Scientific Secures Key Patent Approvals in U.S. and Europe
Express News | Milestone Scientific Shares Are Trading Higher After the Company Announced the Medicare Price Assignment for Its CompuFlo Epidural System
Express News | EXCLUSIVE: Milestone Scientific Tells Benzinga 'This New Price Assignment Applies to Two Medicare Regions: Jurisdiction L (JL) and Jurisdiction H (JH)'